The Brain Tumor Center at Johns Hopkins is one of the largest brain tumor treatment and research centers in the world. We treat an extremely large number of patients affected by all types of brain tumors. We tailor the best and most advanced therapies that each unique tumor demands. Our team consists of skilled surgeons and neurologists that can provide the most effective and safest treatment -- even on the most challenging types of tumors.
In addition, our research program has an unparalleled history of introducing new forms of treatment for the patients affected by malignant brain tumors. For example, the only two new effective surgical treatments for malignant brain tumors approved by FDA (Gliadel and Gliasite) were discovered and developed right here at Johns Hopkins. Our national leading role in the design and the completion of multi-center clinical trials allows us to apply the most promising discoveries from the laboratory to patient care in an effective and expeditious fashion. Presently, our most exciting areas of research include immunotherapy of brain tumors, adult stem cells and the local delivery of a variety of new treatments.
Our strong team of experts works closely together in a rigorous interdisciplinary fashion and combines the latest imaging and modern monitoring methods to offer an unparalleled variety of treatment approaches. Our strong support staff assists patients and families coping with these difficult diagnoses.
Last updated: 5/13/09
